ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Carbohydrate Research
Volume 341, Issue 14, 16 October 2006, Pages 2426-2433
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (192 K)

  E-mail Article   
  Add to my Quick Links   
Bookmark and share in 2collab (opens in new window)
Request permission to reuse this article
  Cited By in Scopus (0)
 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
Special issue
View Record in Scopus
 
doi:10.1016/j.carres.2006.07.006    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2006 Elsevier Ltd All rights reserved.

Note

Synthesis of Lewis A trisaccharide analogues in which d-glucose and l-rhamnose replace d-galactose and l-fucose, respectively

Liang Liaoa and France-Isabelle AuzanneauCorresponding Author Contact Information, a, E-mail The Corresponding Author

aDepartment of Chemistry, University of Guelph, Guelph, Ontario, Canada N1G 2W1

Received 12 June 2006; 
revised 6 July 2006; 
accepted 12 July 2006. 
Available online 1 August 2006.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

In our effort to design a safe anti-cancer vaccine based on the tumor associated carbohydrate antigen LeaLex, we are studying the cross-reactivity between the Lea natural trisaccharide antigen and analogues in which the l-fucose, d-galactose, and/or d-glucosamine residues are replaced by l-rhamnose or d-glucose, respectively. We describe here the chemical synthesis of two such Lea trisaccharide analogues. In one trisaccharide, d-glucose replaces d-galactose and in the second analogue l-rhamnose and d-glucose replace l-fucose and d-galactose, respectively. Introduction of the rhamnose and fucose moiety onto the poorly reactive 4-OH group of the N-acetylglucosamine residue in a disaccharide acceptor was successful after bis-N-acetylation of the amine group. These analogues will be used in competitive binding experiments with anti-Lea antibodies and their solution conformations will be studied.

Graphical abstract


Keywords: Synthetic carbohydrate-based anti-cancer vaccines; Cross-reactivity; Auto-immune reactions; LeaLex analogues; Lea analogues; GlcNAc-containing acceptors

Article Outline

1. Experimental
1.1. General methods
1.2. Methyl 2-acetamido-3-O-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)-4,6-O-benzylidene-2-deoxy-β-d-glucopyranoside (6)
1.3. Methyl 2-(N-acetylacetamido)-3-O-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)-6-O-benzyl-2-deoxy-β-d-glucopyranoside (7)
1.4. Methyl 2-(N-acetylacetamido)-3-O-(2,3,4,6-tetra-O-acetyl-β-d-galactopyranosyl)-6-O-benzyl-2-deoxy-β-d-glucopyranoside (8)
1.5. Methyl 2-(N-acetylacetamido)-3-O-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)-6-O-benzyl-4-O-(2,3,4-tri-O-benzyl-α-l-fucopyranosyl)-2-deoxy-β-d-glucopyranoside (11)
1.6. Methyl 2-(N-acetylacetamido)-3-O-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)-4-O-(2,3,4-tri-O-acetyl-α-l-rhamnopyranosyl)-6-O-benzyl-2-deoxy-β-d-glucopyranoside (12)
1.7. Methyl 2-acetamido-6-O-benzyl-4-O-(2,3,4-tri-O-benzyl-α-l-fucopyranosyl)-2-deoxy-3-O-(β-d-glucopyranosyl)-β-d-glucopyranoside (13)
1.8. Methyl 2-acetamido-2-deoxy-β-d-glucopyranosyl-(1→3)-[α-l-fucopyranosyl-(1→4)]-β-d-glucopyranoside (2)
1.9. Methyl 2-acetamido-6-O-benzyl-2-deoxy-3-O-(β-d-galactopyranosyl)-4-O-(α-l-rhamnopyranosyl)-β-d-glucopyranoside (14)
1.10. Methyl 2-acetamido-β-d-glucopyranosyl-(1→3)-[α-l-rhamnopyranosyl-(1→4)]-2-deoxy-β-d-glucopyranoside (3)
Acknowledgements
Supplementary data
References



Carbohydrate Research
Volume 341, Issue 14, 16 October 2006, Pages 2426-2433
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.